Population Pharmacokinetics and Limited Sampling Strategy of Mycophenolate Mofetil for Patients in Early Period After Kidney Transplantation

Documenti analoghi

• De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care
  di: Hanna L. Kleiboeker, et al.
  Pubblicazione: (2025)
• Sirolimus Versus Mycophenolate Mofetil in Simultaneous Pancreas–Kidney Transplantation: Impact on Urinary Tract Infection Rates
  di: Barbora Píšová, et al.
  Pubblicazione: (2026)
• External Validation of a Limited Sampling Strategy for the Estimation of Mycophenolic Acid Exposure Between Different Assay Methods: PETINIA and HPLC Methods
  di: Kosuke Doki, et al.
  Pubblicazione: (2024)
• Early Onset Mycoplasma spp. Infection After Kidney Transplantation: A Systematic Review
  di: Carlo Galdino Riva, et al.
  Pubblicazione: (2025)
• Review–Long‐Term Care of Kidney Transplant Patients
  di: Ron Shapiro
  Pubblicazione: (2024)